4201 - 4225 of 6230 Results
Title
Year
-
OPENTitle: Denitrogenative Alkylation of K-Ras(G12D) Inhibits Oncogenic Signaling in Cancer CellsJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 147Issue #: 28Start Page: 24785End Page: 24792Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/jacs.5c06745Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/jacs.5c06745Citation Count: 0
-
OPENTitle: Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic HypotensionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 3Start Page: 298End Page: 308Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12478Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12478Citation Count: 76
-
OPENTitle: LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8Journal Name: CellsPublisher: MDPI AGVol: 10Issue #: 2Start Page: 203End Page: 203Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10020203Best OA location URL: https://www.mdpi.com/2073-4409/10/2/203/pdf?version=1611625974Citation Count: 1
-
OPENTitle: Competitive HIF Prolyl Hydroxylase Inhibitors Show Protection against Oxidative Stress by a Mechanism Partially Dependent on GlycolysisJournal Name: ISRN NeurosciencePublisher: WileyVol: 2013Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2013/598587Best OA location URL: https://downloads.hindawi.com/archive/2013/598587.pdfCitation Count: 6
- The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR22016OPENTitle: The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR2Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2015.00089Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2015.00089/pdfCitation Count: 59
-
OPENTitle: Multimodal MRI evaluation of parkinsonian limbic pathologiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 76Issue #:Start Page: 194End Page: 200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.01.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6461740Citation Count: 14
-
OPENTitle: From iPS Cells to Rodents and Nonhuman Primates: Filling Gaps in Modeling Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 832End Page: 841Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28387Citation Count: 16
-
OPENTitle: LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0679-5Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0679-5Citation Count: 45
-
OPENTitle: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 142Issue #: 5Start Page: 756End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14104Citation Count: 102
-
OPENTitle: Combating Parkinson’s disease-associated toxicity by modulating proteostasisJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 5Start Page: 803End Page: 804Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1620082114Best OA location URL: https://www.pnas.org/content/pnas/114/5/803.full.pdfCitation Count: 4
-
OPENTitle: Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease GeneticsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1559End Page: 1561Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29042Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.29042Citation Count: 10
-
OPENTitle: Subcortical short‐term plasticity elicited by deep brain stimulationJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 5Start Page: 1010End Page: 1023Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51275Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51275Citation Count: 31
-
OPENTitle: Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodiesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 10Start Page: 769End Page: 780Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.337Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.337Citation Count: 60
-
OPENTitle: Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia are more frequent in advanced versus early Parkinson’s diseaseJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 44Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsab067Best OA location URL: https://academic.oup.com/sleep/article-pdf/44/9/zsab067/45297401/zsab067.pdfCitation Count: 24
-
OPENTitle: Effect of the mGlu2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmosetJournal Name: European Journal of NeurosciencePublisher: WileyVol: 60Issue #: 9Start Page: 6175End Page: 6184Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ejn.16454Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejn.16454Citation Count: 2
-
OPENTitle: Treatment response to onabotulinumtoxinA in cervical dystonia patients with anterocollis and retrocollisJournal Name: ToxiconPublisher: Elsevier BVVol: 248Issue #:Start Page: 108035End Page: 108035Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.toxicon.2024.108035Best OA location URL: https://doi.org/10.1016/j.toxicon.2024.108035Citation Count: 2
-
OPENTitle: Liganded magnetic nanoparticles for magnetic resonance imaging of α-synucleinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00918-zBest OA location URL: https://www.nature.com/articles/s41531-025-00918-z.pdfCitation Count: 0
-
OPENTitle: Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 2Start Page: 106End Page: 121Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51482Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51482Citation Count: 31
-
OPENTitle: Joint modeling of multivariate longitudinal data and survival data in several observational studies of Huntington’s diseaseJournal Name: BMC Medical Research MethodologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12874-018-0592-9Best OA location URL: https://bmcmedresmethodol.biomedcentral.com/track/pdf/10.1186/s12874-018-0592-9.pdfCitation Count: 49
- Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition2019OPENTitle: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competitionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104577End Page: 104577Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104577Citation Count: 40
-
OPENTitle: Dying-back of ascending noradrenergic projections in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 9Start Page: 2562End Page: 2564Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab286Best OA location URL: https://academic.oup.com/brain/article-pdf/144/9/2562/40880422/awab286.pdfCitation Count: 6
-
OPENTitle: Interactome Screening Identifies the ER Luminal Chaperone Hsp47 as a Regulator of the Unfolded Protein Response Transducer IRE1αJournal Name: Molecular CellPublisher: Elsevier BVVol: 69Issue #: 2Start Page: 238End Page: 252.e7Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2017.12.028Best OA location URL: http://www.cell.com/article/S1097276517310079/pdfCitation Count: 154
-
OPENTitle: GABAA Receptor Benzodiazepine Binding Sites and Motor Impairments in Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 13Issue #: 12Start Page: 1711End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci13121711Best OA location URL: https://www.mdpi.com/2076-3425/13/12/1711/pdf?version=1702360159Citation Count: 5
-
OPENTitle: Gray Matter Volume Loss in Proposed Brain‐First and Body‐First Parkinson's Disease SubtypesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2066End Page: 2074Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29172Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.29172Citation Count: 22
-
OPENTitle: The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synucleinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 110Issue #:Start Page: 68End Page: 81Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2017.11.006Best OA location URL: https://doi.org/10.1016/j.nbd.2017.11.006Citation Count: 44